Patents by Inventor Christopher S.P. McErlean

Christopher S.P. McErlean has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hsp90 inhibitors with modified toxicity
    Patent number: 8551964
    Abstract: The invention provides 19-substituted geldanamycin derivatives, pharmaceutically acceptable salts thereof and prodrugs thereof that are potent Hsp90 binding agents useful for the treatment of, and/or the amelioration of symptoms of, cancer and other proliferative tissue disorders.
    Type: Grant
    Filed: August 22, 2008
    Date of Patent: October 8, 2013
    Assignee: The Regents of the University of Colorado
    Inventors: David Ross, David Siegel, Wenchang Guo, Christopher J. Moody, Christopher S. P. McErlean
  • HSP90 INHIBITORS WITH MODIFIED TOXICITY
    Publication number: 20120022011
    Abstract: The invention provides purified 19-substituted geldanamycin derivatives, pharmaceutically acceptable salts thereof and prodrugs thereof that are potent Hsp90 binding agents that are useful for the treatment and/or the amelioration of symptoms of cancer and other proliferative tissue disorders.
    Type: Application
    Filed: August 22, 2008
    Publication date: January 26, 2012
    Applicant: The Regents of the University of Colorado
    Inventors: David Ross, David Siegel, Wenchang Guo, Christopher J. Moody, Christopher S.P. McErlean